Related Experiment Video
Updated: May 25, 2026

Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
Published on: June 16, 2011
Involvement of thioredoxin-interacting protein (TXNIP) in glucocorticoid-mediated beta cell death
E Reich1, A Tamary, R Vogt Sionov
1Department of Endocrinology, Hadassah University Hospital, Jerusalem, Israel.
Aim/Hypothesis:
Glucocorticoid hormones (GCs) are widely used to treat a variety of inflammatory and immune diseases. However, their long-term administration is associated with adverse metabolic effects, including glucose intolerance and diabetes. Our objective was to elucidate the mechanisms by which GCs affect beta cell survival with a specific emphasis on the role of the thioredoxin-interacting protein (TXNIP) in beta cell apoptosis.
Methods:
Human and mouse islets, together with MIN6 beta cells, were exposed to dexamethasone (Dex) and apoptosis was assessed by measuring the percentage of sub-G1 cells, the appearance of cleaved caspase-3 or by using a TUNEL assay. Dex-upregulated expression of Txnip mRNA was analysed by real-time PCR, and GC-modulated production and modification of proteins were determined by western blotting.
Results:
We provide evidence that TXNIP, a negative regulator of the antioxidant thioredoxin (TRX), is strongly induced in beta cells by GCs and that its induction is dependent on p38 mitogen-activated protein kinase (MAPK) activation. TXNIP downregulation by RNA interference, overexpression of the radical scavenger TRX1 or elevation of intracellular cAMP levels attenuated the Dex-mediated apoptosis. Dex-induced Txnip expression and beta cell apoptosis are mediated by the glucocorticoid receptor (GR), as the GR antagonist RU486 fully abolishes these effects.
Conclusions/Interpretation:
Altogether, our data suggest TXNIP as a novel mediator of GC-induced apoptosis in beta cells and further contribute to our understanding of beta cell death pathways.
Insights
Glucocorticoids induce beta cell apoptosis via thioredoxin-interacting protein (TXNIP) upregulation, mediated by the glucocorticoid receptor (GR) and p38 MAPK. Reducing TXNIP or enhancing thioredoxin (TRX) protects beta cells from this death pathway.
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Biology
Background:
- Glucocorticoids (GCs) are vital anti-inflammatory drugs but can cause metabolic side effects like diabetes.
- Long-term GC use is linked to impaired glucose metabolism and beta cell dysfunction.
Purpose of the Study:
- To investigate the mechanisms by which GCs induce beta cell apoptosis.
- To determine the specific role of thioredoxin-interacting protein (TXNIP) in GC-induced beta cell death.
Main Methods:
- Treated human/mouse islets and MIN6 beta cells with dexamethasone (Dex).
- Assessed apoptosis using sub-G1 cell analysis, cleaved caspase-3, and TUNEL assays.
- Analyzed TXNIP mRNA and protein levels via real-time PCR and western blotting.
Main Results:
- Dexamethasone strongly induced TXNIP expression in beta cells, dependent on p38 MAPK activation.
- TXNIP downregulation, TRX1 overexpression, or increased cAMP attenuated Dex-induced apoptosis.
- Glucocorticoid receptor (GR) mediated Dex-induced TXNIP expression and apoptosis, as shown by RU486 antagonism.
Conclusions:
- TXNIP is a novel mediator of GC-induced beta cell apoptosis.
- These findings elucidate key pathways involved in GC-induced beta cell death.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Type I Diabetes II: Pathophysiology
The Intrinsic Apoptotic Pathway
TGF - β Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...

